For these reasons, drugs that target the RAAS, such as ACE inhibitors (introduced in 1981) and Ang II receptor blockers (ARBs), are among the most important therapeutic agents available today for the treatment of hypertension, heart failure, coronary artery disease, renal insufficiency, and general atherosclerosis [8]. The gene discussed is ACE; the disease is Hypertension.